The Biden Administration is working on a plan to make Pfizer’s Covid-19 antiviral pill Paxlovid available across the US following shortages of the lifesaving drug, Bloomberg reported Friday, sitting an anonymous administration official.

Key Facts

- Advertisement -

The Biden Administration will announce next week a plan to enable all US pharmacies to order Paxlovid, greatly increasing the drug’s accessibility to people at risk of serious Covid-19 symptoms, Bloomberg reported.

The administration has already ordered 20 million courses of Paxlovid—or 600 million pills—for 2022, with about 10 million courses due by the end of June and the remaining 10 million due by the end of September.

Though Pfizer’s trials show Paxlovid can reduce the risk of hospitalization or death from Covid-19 by 89%, it remains underutilized, White House chief medical adviser Dr. Anthony Fauci told NBC April 13.

The White House and Pfizer did not immediately respond to requests for comment.